Syndax Pharmaceuticals (SNDX) Shares Soar 9.09% After Hitting 2020 Low

Syndax Pharmaceuticals (SNDX) shares surged by 9.09% today, marking a significant rebound after hitting its lowest level since April 2020 earlier in the day, with an intraday decline of 8.52%.

One of the key factors influencing Syndax's stock price is the recent insider activities and the opinions of analysts. The company's stock hitting a new 12-month low, with a 3.5% decline, suggests that these activities and opinions may have negatively impacted investor sentiment. This could be a significant factor in the recent volatility of the stock price.

Syndax's participation in the Stifel 2025 Virtual Targeted Oncology Forum on April 9, 2025, could also play a role in shaping investor perceptions. Any announcements or strategic plans discussed during the forum could potentially affect the stock price, as investors closely monitor the company's developments and future outlook.

Additionally, Syndax's financial performance, particularly the decrease in free cash flow for the 2024 fiscal year, might have contributed to the stock's decline. This financial indicator suggests potential challenges that the company may be facing, which could further influence investor confidence and stock performance.